uniQure's brain disorder drug meets trial goal
24/09/2025 12:10
Sept 24 (Reuters) - uniQure UQ1.F said on Wednesday its experimental brain disorder drug met the main goal in an early-to-mid stage trial. (Reporting by Kamal Choudhury in Bengaluru; Editing by Sahal Muhammed) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal